Treatment of Nonmetastatic Castration-Resistant Prostate Cancer.

Treatment of Nonmetastatic Castration-Resistant Prostate Cancer.

Patients with nonmetastatic castration-resistant prostate cancer (CRPC) are a heterogeneous population with regard to risk of progression to metastatic disease. Treatment selection for nonmetastatic CRPC must balance the risk of disease progression

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Write a comment

*